The Societal Economic Impact of Secukinumab in First-Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open-Cohort Simulation

OBJECTIVES: Moderate to severe plaque psoriasis is a chronic inflammatory disease. In Germany, guidelines recommend fumaric acid esters (FAEs) as first-line systemic treatment. Despite treatment with FAEs, disease burden remains high in Germany. Secukinumab, a fully human monoclonal antibody, has de...

Descripción completa

Detalles Bibliográficos
Autores principales: Seddik, Ahmed H., Melzer, Nima, Tsotra, Foteini, Ostwald, Dennis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864046/
https://www.ncbi.nlm.nih.gov/pubmed/34668167
http://dx.doi.org/10.1007/s41669-021-00305-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864046/
https://www.ncbi.nlm.nih.gov/pubmed/34668167
http://dx.doi.org/10.1007/s41669-021-00305-3

Ejemplares similares